Drug recall · May 15, 2024
Timolol Maleate Ophthalmic Solution recall
Why: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ
- Lots / codes
Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.
- Quantity
- 382,104 units
- Company
- FDC Limited, Aurangabad, Maharashtra State, N/A
- Distribution
- New Jersey Only
- Initiated
- April 25, 2024 · Voluntary: Firm initiated
- Classified
- May 7, 2024
- Reported
- May 15, 2024
- Ended
- May 21, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.